Old Web
English
Sign In
Acemap
>
authorDetail
>
P. Riebling
P. Riebling
Biology
Ataluren
Duchenne muscular dystrophy
Genetics
Nonsense mutation
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
P.407 - Design of a phase 3 trial to evaluate the long-term efficacy and safety of ataluren in patients with nonsense mutation Duchenne muscular dystrophy
2017
Neuromuscular Disorders
P. Riebling
E. O'Mara
X. Luo
P Trifillis
T. Ong
Show All
Source
Cite
Save
Citations (0)
A phase 2 trial of the safety and pharmacokinetics of ataluren in patients aged 2 to 5 years with nonsense mutation Duchenne muscular dystrophy
2017
Neuromuscular Disorders
P. Riebling
R. Kong
E. O'Mara
X. Luo
P Trifillis
T. Ong
Show All
Source
Cite
Save
Citations (1)
Clinical Characteristics of 22 Families With Schnyder's Crystalline Corneal Dystrophy
2004
Investigative Ophthalmology & Visual Science
J.S. Weiss
S.B. Muenk
V. Theendakara
Gerard Tromp
T. Tervo
P. Riebling
Maria Hoeltzenbein
Wolfram Henn
Helena Kuivaniemi
Show All
Source
Cite
Save
Citations (1)
1